Alpheus Medical nets $52M to trial ultrasound-activated brain tumor therapy
After publishing early clinical results of its ultrasound-activated brain tumor therapy this year, Alpheus Medical has raised $52 million in venture capital funding to support a new randomized trial.
After publishing early clinical results of its ultrasound-activated brain tumor therapy this year, Alpheus Medical has raised $52 million in venture capital funding to support a new randomized trial.
